Leerink Partnrs Issues Optimistic Estimate for INSP Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Equities researchers at Leerink Partnrs raised their Q1 2025 EPS estimates for shares of Inspire Medical Systems in a research note issued on Tuesday, February 11th. Leerink Partnrs analyst M. Kratky now forecasts that the company will post earnings per share of ($0.18) for the quarter, up from their prior estimate of ($0.25). The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ Q2 2025 earnings at $0.46 EPS, Q3 2025 earnings at $0.60 EPS, Q4 2025 earnings at $1.25 EPS, FY2025 earnings at $2.14 EPS, FY2026 earnings at $3.28 EPS, FY2027 earnings at $4.27 EPS and FY2029 earnings at $6.80 EPS.

Other equities analysts have also issued research reports about the stock. Robert W. Baird dropped their target price on shares of Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating on the stock in a research report on Tuesday. Stifel Nicolaus reduced their target price on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research note on Tuesday, January 21st. Truist Financial lowered their price target on Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a research note on Tuesday. Piper Sandler reduced their price objective on Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating for the company in a research report on Monday. Finally, KeyCorp restated an “overweight” rating and set a $234.00 price objective (down from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Inspire Medical Systems has an average rating of “Moderate Buy” and a consensus target price of $228.82.

Inspire Medical Systems Stock Up 1.7 %

Shares of NYSE INSP opened at $187.17 on Thursday. Inspire Medical Systems has a 12 month low of $123.00 and a 12 month high of $257.40. The company has a market cap of $5.61 billion, a P/E ratio of 174.93 and a beta of 1.32. The business’s 50 day moving average is $189.39 and its two-hundred day moving average is $191.39.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%.

Institutional Investors Weigh In On Inspire Medical Systems

Hedge funds and other institutional investors have recently bought and sold shares of the business. Mutual of America Capital Management LLC boosted its stake in Inspire Medical Systems by 1.2% in the fourth quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company’s stock worth $842,000 after purchasing an additional 55 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Inspire Medical Systems by 1.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock worth $1,461,000 after buying an additional 79 shares in the last quarter. Xponance Inc. lifted its position in Inspire Medical Systems by 2.2% during the 4th quarter. Xponance Inc. now owns 3,824 shares of the company’s stock worth $709,000 after buying an additional 82 shares in the last quarter. Signaturefd LLC grew its holdings in Inspire Medical Systems by 45.9% during the 3rd quarter. Signaturefd LLC now owns 270 shares of the company’s stock worth $57,000 after acquiring an additional 85 shares during the last quarter. Finally, Harbour Investments Inc. increased its position in Inspire Medical Systems by 101.0% in the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company’s stock valued at $37,000 after acquiring an additional 99 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.